Gnothis R&D, hubs
Gnothis represents a unique source of knowledge within the field of molecular medicine. Gnothis was founded year 2000 by Professor Rudolf Rigler as well as a gremium of leading scientists, supported by institutional as well as private investors. The company covered two operational units: Gnothis AB, Kista, Sweden, and Gnothis SA, Lausanne, Switzerland. During the years 2000-2003 these operational units developed the Direct Gene expression Analysis (DGA) application and made considerable research and development concerning single-molecule DNA sequencing.
In June 2003 a strategic partnership was initiated with Evotec Technologies GmbH, Hamburg, Germany. The purpose of the partnership with Evotec Technologies GmbH is to enable a full scale commercialization of Direct Gene expression Analysis (DGA).
In June 2003 a strategic partnership was initiated with Evotec Technologies GmbH, Hamburg, Germany. The purpose of the partnership with Evotec Technologies GmbH is to enable a full scale commercialization of Direct Gene expression Analysis (DGA).
Technology:
Precision Medicine
Industry:
P3 Medicine
Headquarters:
Lausanne, Vaud, Switzerland
Founded Date:
2000
Employees Number:
1-10
Funding Status:
Undisclosed
Register and Claim Ownership